A comparison of the efficacy of Chinese herbal medicines in the treatment of primary dysmenorrhea

Abstract

Introduction: Chinese herbal medicines (CHM) have been commonly used in the treatment of primary dysmenorrhea in East Asia. Several systematic reviews have been conducted to assess the clinical efficacy of CHM in the treatment of primary dysmenorrhea. However, their comparative efficacy is still unclear. Therefore, the purpose of this study is to conduct a network meta-analysis (NMA) to systematically compare the advantages of different CHM in the treatment of primary dysmenorrhea. Methods and analysis: The following electronic databases will be searched in this study: Web of Science, PubMed, Cochrane Library, Chinese Biomedical Literature Database, Chinese National Knowledge Infrastructure, Chinese Scientific Journal Database, and Wan-fang Database. Search terms include (Chinese herbal medicine or Chinese patent medicine or medicinal plants or phytotherapy or traditional medicine or Chinese herbal drugs or plant extracts or herbal medicine or herbal extract or herb or traditional Chinese medicine) and (primary dysmenorrhea or dysmenorrhea or painful menstruation) and (randomized controlled trial). The language will be limited to Chinese and English, and the search date will be up to May 2019. The included studies must be randomized controlled trials (RCTs) with patients diagnosed with primary dysmenorrhea. CHM must be used as interventions in the experimental group. While in the control group, studies that used a different herbal medicine, nonsteroidal anti-inflammatory drugs (NSAIDs), or placebo will be included. The primary outcomes include clinical efficacy and visual analog scale (VAS), and the secondary outcomes include adverse events and quality of life. Four reviewers will independently extract the data and assess the qualities of the studies. Statistical analysis will be conducted with R package for each outcome. Ethics and dissemination: Ethical approval is not required as this NMA is based on published studies. The completed NMA will be published in a peer-reviewed scientific journal. Trial registration number: PROSPERO CRD42018095254.

To explore the mechanism of acupoint application in the treatment of primary dysmenorrhea by 16S rDNA sequencing and metabolomics

“…However, at present, the treatment of PD in modern medicine is mostly symptomatic treatment, and there is no speci c drug. Western medicine analgesic treatment can only alleviate the clinical symptoms, can not be completely cured, can not achieve the desired therapeutic effect [17][18][19][20] . The treatment of PD with traditional Chinese medicine has a rich theoretical system and clinical experience, and it is regarded as an advantageous disease in the treatment of traditional Chinese medicine 21,22 .…”

Insight into Dysmenorrhea Research from 1992 to 2022: A Bibliometric Analysis

“… 73 In addition, research on traditional Chinese medicine and herbal medicine for dysmenorrhea treatment has also been a hotspot in recent years. 74 Among them, Shaofu-Zhuyu decoction can effectively relieve menstrual pain. 75 , 76 Transcutaneous electrical nerve stimulation, acupuncture, and surgical interventions have also been shown to relieve menstrual pain.…”

Getting Rid of Bomb Pushing the Womb : Dysmenorrhea Management

“…Chinese herbal medicines (CHM) are well-accepted in the treatment of primary dysmenorrhea in East Asia, such as China, Korea, and Japan. Reviews from Gao et al [57] showed a significant advantage compared with other treatments. Sharghi et al [27] demonstrated that medicinal plants, drugs, and acupressure seem to suppress pain by reducing the level of prostaglandins, mediating nitric oxide, increasing beta-endorphin levels, blocking the calcium channel, and enhancing circulatory flow through the uterine pathway.…”